Deanne Miller
Directeur des opérations chez IMMUTEP LIMITED
Fortune : 912 297 $ au 30/04/2024
Profil
Deanne Miller is currently the Co-Managing Director at Immutep GmbH and the COO, Secretary & General Counsel at Immutep Ltd.
She is also a Member of The Law Society of New South Wales.
Previously, she worked as an Associate Director at Westpac Banking Corp., a Manager-Legal & Compliance at Macquarie Group Ltd., and a Legal Counsel at RBC Investor Services Trust (Australia).
Ms. Miller completed her undergraduate and graduate degrees at The University of Sydney.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUTEP LTD
0,27% | 22/08/2023 | 3 267 305 ( 0,27% ) | 912 297 $ | 30/04/2024 |
Postes actifs de Deanne Miller
| Sociétés | Poste | Début |
|---|---|---|
| IMMUTEP LIMITED | Directeur des opérations | 01/11/2016 |
| The Law Society of New South Wales | Corporate Officer/Principal | - |
Immutep GmbH
 Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. | Directeur Général | - |
Anciens postes connus de Deanne Miller
| Sociétés | Poste | Fin |
|---|---|---|
| MACQUARIE GROUP LIMITED | Compliance Officer | - |
| RBC Investor Services Trust (Australia) | Conseiller Juridique Général | - |
| WESTPAC BANKING CORPORATION | Corporate Officer/Principal | - |
Formation de Deanne Miller
| The University of Sydney | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| WESTPAC BANKING CORPORATION | Finance |
| IMMUTEP LIMITED | Health Technology |
| MACQUARIE GROUP LIMITED | Finance |
| Entreprise privées | 3 |
|---|---|
| The Law Society of New South Wales | |
| RBC Investor Services Trust (Australia) | Finance |
Immutep GmbH
Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. | Health Technology |
